We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$330M
AUM Growth
+$61.9M
Cap. Flow
+$39.2M
Cap. Flow %
11.89%
Top 10 Hldgs %
62.41%
Holding
32
New
4
Increased
15
Reduced
8
Closed
3

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$18.1M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.6M
3
QGEN icon
Qiagen
QGEN
+$6.19M
4
MDT icon
Medtronic
MDT
+$5.89M
5
CVS icon
CVS Health
CVS
+$4.78M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10M
2
ABT icon
Abbott
ABT
+$7.27M
3
AMGN icon
Amgen
AMGN
+$4.58M
4
THC icon
Tenet Healthcare
THC
+$4.01M
5
UHS icon
Universal Health Services
UHS
+$3.74M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
26
Lantheus
LNTH
$6.8B
$3.48M 1.06%
31,712
AGIO icon
27
Agios Pharmaceuticals
AGIO
$2.38B
$3.02M 0.92%
67,908
-53,936
-44% -$2.45M
ALKS icon
28
Alkermes
ALKS
$8.62B
$2.8M 0.85%
100,000
-94,000
-48% -$2.51M
LEGN icon
29
Legend Biotech
LEGN
$4.49B
$1.89M 0.57%
+38,762
New +$2.06M
ABT icon
30
Abbott
ABT
$177B
-70,000
Closed -$7.27M
ALNY icon
31
Alnylam Pharmaceuticals
ALNY
$36.4B
-15,240
Closed -$3.7M
VTRS icon
32
Viatris
VTRS
$19.8B
-103,106
Closed -$1.1M

Similar funds

Sector Gamma AS's Q3 2024 Portfolio in Review

As of Q3 2024, Sector Gamma AS held 32 positions worth $330M, up 23% from $268M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Sector Gamma AS deployed $39.2M of net new capital in Q3 2024, opening 4 new positions and adding to 15 existing holdings. Its largest new stake was Becton Dickinson: 77,280 shares worth $18.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Gilead Sciences, an estimated $10M trimmed.

  • Sector Gamma AS's largest Q3 2024 buy was Becton Dickinson: 77,280 shares worth $18.6M.
  • Sector Gamma AS added most to BioMarin Pharmaceuticals in Q3 2024, an estimated $10.6M increase.
  • Sector Gamma AS's biggest Q3 2024 reduction was Gilead Sciences, cutting an estimated $10M.
  • Sector Gamma AS fully exited Abbott in Q3 2024, selling an estimated $7.27M.
  • Sector Gamma AS's ten largest holdings make up 62% of its $330M portfolio in Q3 2024.
  • Sector Gamma AS opened 4 new positions and closed 3 in Q3 2024.
  • Sector Gamma AS's portfolio value rose 23% quarter-over-quarter to $330M.

Based on Sector Gamma AS's 13F filing for Q3 2024, filed 13 Nov 2024.